The Biotech Growth Trust PLC (LON:BIOG – Get Free Report)’s stock price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 823.62 ($10.69) and traded as low as GBX 726 ($9.43). The Biotech Growth Trust shares last traded at GBX 754 ($9.79), with a volume of 503,509 shares traded.
The Biotech Growth Trust Trading Down 1.6 %
The company has a market capitalization of £210.27 million, a PE ratio of 2.47 and a beta of 0.50. The firm’s 50 day moving average is GBX 821.66 and its 200 day moving average is GBX 908.29. The company has a debt-to-equity ratio of 11.02, a current ratio of 0.59 and a quick ratio of 0.00.
Insider Activity at The Biotech Growth Trust
In other news, insider Nicola Shepherd purchased 1,000 shares of the company’s stock in a transaction on Monday, January 13th. The stock was acquired at an average cost of GBX 846 ($10.99) per share, for a total transaction of £8,460 ($10,985.59). 0.71% of the stock is currently owned by insiders.
The Biotech Growth Trust Company Profile
The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).
Featured Stories
- Five stocks we like better than The Biotech Growth Trust
- Manufacturing Stocks Investing
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Health Care Stocks Explained: Why You Might Want to Invest
- The 3 Most Talked About Investments on WallStreetBets Right Now
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for The Biotech Growth Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Biotech Growth Trust and related companies with MarketBeat.com's FREE daily email newsletter.